Despite the pandemic, Czech biotech company Contipro has
managed to achieve a turnover of more than CZK 1bn in 2021. The
year-on-year growth was 17.9% and almost half of the company's
sales were generated by the sale of hyaluronic acid for
pharmaceutical use. Contipro is looking for qualified employees for
various positions and is also modernising the entire company's
facilities. Last year, the company commissioned a new building for
the scientific research centre of GLP laboratories and expanded the
scientific research facilities with additional instruments.
www.cianews.cz